Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Likar, R; Köstenberger, M; Nahler, G.
[Cannabidiol in cancer treatment].
Schmerz. 2020; 34(2):117-122
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Köstenberger Markus

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Cannabis was used for cancer patients as early as about 2500 years ago. Experimental studies demonstrated tumor-inhibiting activities of various cannabinoids more than 40 years ago. In view of the status of tetrahydrocannabinol (THC) as a regulated substance, non-psychotomimetic cannabidiol (CBD) is of particular importance. Efficacy of pure CBD in various animal models as well as initial results (case reports) from patients. Review of the literature on animal experiments and observations in humans. Preclinical studies, particularly recent ones, including numerous animal models of tumors, unanimously suggest the therapeutic efficacy of CBD. In isolated combination studies, synergistic effects were generally observed. In addition, CBD may potentially play a role in the palliative care of patients, especially concerning symptoms such as pain, insomnia, anxiety, and depression. Further human studies are warranted.

Find related publications in this database (Keywords)
Cannabidiol (CBD)
Malignant disease
© Med Uni Graz Impressum